Chronic intranasal administration of fibrillar structures of proinflammatory S100A9 protein impaired passive avoidance learning in old C57Bl/6 mice. Combined treatment with S100A9 fibrils and antibodies to glutamate was followed by an increase in horizontal locomotor activity of animals in the open-field test and did not disturb spatial memory. The increase in the incidence of cognitive disorders in elderly and old people is an urgent problem of modern society. Alzheimer's disease (AD) is the most common type of dementia. The major symptoms of this chronic neurodegenerative disease include memory, thinking, and behavioral disturbances. Little is known about the mechanisms of cognitive deficit in AD [3] .
The increase in the incidence of cognitive disorders in elderly and old people is an urgent problem of modern society. Alzheimer's disease (AD) is the most common type of dementia. The major symptoms of this chronic neurodegenerative disease include memory, thinking, and behavioral disturbances. Little is known about the mechanisms of cognitive deficit in AD [3] .
Disturbed conformation of some proteins and peptides is a molecular mechanism leading to apoptotic death of neurons and subsequent development of dementia. Some misfolded proteins can form pathological aggregates that are deposited in brain parenchyma (e.g., senile plaques of β-amyloid protein [2, 5] ) and induce degeneration of neurofilaments with the formation of neurofibrillary tangles. These changes contribute to activation of microglia, induction of the endosomal-lysosomal signaling system in cells [2] , inhibition of tissue oxidative systems [7] , neuroinflammation [12] , development of glutamate excitotoxicity [10] , and apoptosis [1] .
Along with Aβ 1-42 and tau protein playing a key role in the mechanisms of AD, much attention is paid to proinflammatory S100A9 protein whose expression increases in the microglia (e.g., in the temporal cortex of the brain) during inherited and sporadic AD [14] . S100A9 folding is sometimes impaired with the formation of toxic oligomeric and fibrillar structures of S100A9 (S100A9-FS) and their accumulation (aggregation) in the brain [13, 14] . These changes can serve as a differential marker of early cognitive deficit during AD [6] . Previous studies showed that intranasal administration of monospecific antibodies to glutamate (AB-GL) produces an antiamnesic effect on the model of AD induced by injection of a neurotoxic fragment Ab 25-35 into the Meynert nucleus of adult rats [4] .
This work was designed to study the effect of in vitro synthesized amyloidogenic S100A9-FS on spatial memory formation during passive avoidance conditioning and locomotor activity of animals. We also evaluated the influence of combined treatment with AB-GL and S100A9-FS (intranasally) on old C57Bl/6 mice.
MATERIALS AND METHODS
Experiments were performed on 12-month-old male C57Bl/6 mice (n=60) weighing 31.0±1.0 g. The animals were maintained under standard conditions (12:12-h light/dark regimen) and had free access to water and food.
To obtain S100A9-FS, native protein was dissolved in 10 mM sodium-phosphate buffer (pH 7.4), sonicated for 15 min, and centrifuged on an Eppendorf Centrifuge 5417R at 14,000 rpm. The supernatant was filtered through 0.22-µ filters (Millex) and incubated (concentration 2 mg/ml) in 10 mM sodium-phosphate buffer (pH 7.4) at 37 o C and constant agitation (Eppendorf Thermomixer Compact) for 24 h. The formation of amyloid S100A9-FS was estimated from variations in fluorescence of a staining agent (thioflavin T). Morphological characteristics of S100A9-FS were evaluated by atomic-force microscopy [11] .
Polyclonal monospecific AB-GL were obtained by immunization of Chinchilla rabbits with a conjugate of glutamate and BSA. This conjugate was obtained with a bifunctional reagent glutaraldehyde [13] . The γ-globulin fraction of antibodies was precipitated from serum samples of immunized rabbits with ammonium sulfate (40% saturation) and dialyzed. The γ-globulin fraction was purified from anti-BSA antibodies by means of affinity chromatography (CNBr-Sepharose 4B [Sigma] as a sorbent with immobilized BSA), lyophilized, and stored at 4 o C. The content of AB-GL in serum samples from immunized rabbits was estimated by solid-phase ELISA. The conjugate of glutamate and horse γ-globulin (heterologous protein carrier) was used as a test antigen. The titer of AB-GL was 1:1024±1:16.
C57Bl/6 mice were divided into 5 equal groups. Control animals received physiological saline (4 µl) intranasally for 14 days. Mice of two treatment groups intranasally received S100A9-FS (in vitro individual preparation, 0.48 mg/kg in 4 µl). Animals of the two other groups were treated with S100A9-FS and AB-GL (250 µg/kg in 4 µl).
In series I, the behavior of mice was studied in the open-field test. We recorded the distance of running, time of locomotion and rest, and number of vertical rearing postures. Locomotor activity was evaluated in an automated test with AutoTrack software (OptoVarimex system, Columbus Instruments) for 0-6 min.
In series II, passive avoidance reflex was conditioned in mice. The experimental chamber consisted of light (15.5×15.5×19 cm) and dark (9×9×17 cm) compartments and metal grid floor consisting of rods 0.3 cm in diameter and spaced 0.9 cm apart. Both chambers were connected through a gate with a guillotine door. On day 1, the mice were individually placed into a light compartment illuminated with a 100-W lamp and allowed to familiarize with the chamber for 60 sec. By the end of this session, the door between two compartments was opened. Due to innate holeexploratory behavior typical of rodents, the animal moved to a dark compartment. The latency of transition (LT 1 ) was recorded. When the animal appeared in a dark compartment (with all four limbs and 2 / 3 of the tail), the door was closed and electrocutaneous stimulation (0.3 mA, 1.0 s) was applied, after which each animal was immediately removed and placed in the home cage. The acquired skill was tested after 24 h. The animal was placed in an illuminated compartment for 30 sec to familiarize with the conditions. The door was opened, and the latency of transition into a dark compartment was recorded (LT 2 ). The behavior of animals was studied for 300 sec (beginning from the door opening on days of training and testing). The difference between LT of animal transition into the dark compartment during learning and 24 h after training (ΔLT) reflected the memory retention.
The results were analyzed by Statistica 6.0 software. Several independent samples were compared by one-way nonparametric analysis of variance (Kruskal-Wallis H test) followed by post-hoc analysis (Mann-Whitney U test). The data are presented as M±m. The critical level of statistical significance in null hypothesis testing was taken as 0.05.
RESULTS
The size of S100A9-FS was ~3 nm. The intensity of ThT fluorescence during their formation was elevated by 5.6 times.
The time of locomotion in the open-field test for S100A9-FS-receiving mice was 20.4% greater than in control specimens. However, the distance of running in these animals did no differ from the control. Intranasal administration of S100A9-FS and AB-GL was followed by an increase in the distance of open-field running and time of locomotion by 32 and 35.7%, respectively. The rest period was reduced by 57% under these conditions (as compared to the control). In mice receiving S100A9-FS and AB-GL the time of locomotion was higher (by 12.6%), while the rest period was lower (by 26%) than in S100A9-FS-treated specimens (Table 1) .
Passive avoidance experiments revealed spatial memory impairment on day 15 after administration of S100A9-FS. Aged mice developed spatial memory deficit manifested in LT shortening (ΔLT 28.9±21.6 vs. 144.0±24.6 sec in the control group; p<0.01). In animals receiving AB-GL in combination with S100A9-FS, this parameter did not differ from the control (ΔLT 117.9±34.2 sec).
These data show that S100A9-FS produced an amnesic effect in aged C57Bl/6 mice, which can be related to the development of glutamate excitotoxicity and apoptotic death of neurons in relevant structures of the brain. Combined intranasal treatment with the fraction of amyloidogenic S100A9-FS and AB-GL prevented memory impairment in 12-month-old C57Bl/6 mice. The protective antiamnesic effect was probably associated with the influence of AB-GL on binding of excess glutamate, which reduces the risk of neuronal apoptosis [8, 9] . Combined administration of AB-GL and S100A9-FS was followed by an increase in horizontal activity, but had no effect on vertical activity in the open-field test. These results illustrate the increase in orientation-and-exploratory activity of mice under these conditions. Our findings provide support to the fact that toxic activity of glutamate and S100A9-FS is decreased under these conditions. We conclude that, on the one hand, amyloidogenic fibrillar structures of proinflammatory S100A9 protein are involved in spatial memory impairment. Therefore, these structures can serve as a new molecular component of cognitive disorders during neurodegenerative processes. On the other hand, intranasal administration of monospecific AB-GL in combination with S100A9-FS produced a protective effect and prevented the development of memory disorders in C57Bl/6 mice during aging.
